Compliance to preventive aspirin therapy in patients after acuter myocardial infarction. ACT Study results
The ACT Study (Aspirin underutilization and compliance in Cardiovascular diseases Treatment; 2007-2008) was aimed at evaluating the doctors’ views on long-term, low-dose preventive therapy with acetylsalicylic acid (ASA), as well as at developing the strategy on improving patients’ compliance via a...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2010-10-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2130 |
| _version_ | 1797882665395814400 |
|---|---|
| author | V. M. Gorbunov |
| author_facet | V. M. Gorbunov |
| author_sort | V. M. Gorbunov |
| collection | DOAJ |
| description | The ACT Study (Aspirin underutilization and compliance in Cardiovascular diseases Treatment; 2007-2008) was aimed at evaluating the doctors’ views on long-term, low-dose preventive therapy with acetylsalicylic acid (ASA), as well as at developing the strategy on improving patients’ compliance via a specialised questionnaire. The study took place in 18 European, Latin American, and Asian countries. Despite the fact that ASA therapy was recommended to >90 % of the patients after acute myocardial infarction, the treatment compliance was not adequate: for example, good compliance was observed only in 63 % and 54 % of European and Latin American patients, respectively. The most effective measures to increase the patients’ compliance, as reported by the participating physicians, were using the evidence on preventive effectiveness of long-term ASA therapy, and achieving a consensus between a doctor and a patient. Implementation of these measures requires good knowledge of evidence-based cardiology by the doctors, and more “democratic” doctor-patient relationship. |
| first_indexed | 2024-04-10T03:38:17Z |
| format | Article |
| id | doaj.art-5ac678d3d7ea488d9dc8e413c600b1d6 |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2024-04-10T03:38:17Z |
| publishDate | 2010-10-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-5ac678d3d7ea488d9dc8e413c600b1d62023-03-13T07:23:18Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252010-10-0195951011839Compliance to preventive aspirin therapy in patients after acuter myocardial infarction. ACT Study resultsV. M. Gorbunov0Государственный научно-исследовательский центр профилактической медицины. МоскваThe ACT Study (Aspirin underutilization and compliance in Cardiovascular diseases Treatment; 2007-2008) was aimed at evaluating the doctors’ views on long-term, low-dose preventive therapy with acetylsalicylic acid (ASA), as well as at developing the strategy on improving patients’ compliance via a specialised questionnaire. The study took place in 18 European, Latin American, and Asian countries. Despite the fact that ASA therapy was recommended to >90 % of the patients after acute myocardial infarction, the treatment compliance was not adequate: for example, good compliance was observed only in 63 % and 54 % of European and Latin American patients, respectively. The most effective measures to increase the patients’ compliance, as reported by the participating physicians, were using the evidence on preventive effectiveness of long-term ASA therapy, and achieving a consensus between a doctor and a patient. Implementation of these measures requires good knowledge of evidence-based cardiology by the doctors, and more “democratic” doctor-patient relationship.https://cardiovascular.elpub.ru/jour/article/view/2130ацетилсалициловая кислотаинфаркт миокардаприверженность (compliance)исследование act |
| spellingShingle | V. M. Gorbunov Compliance to preventive aspirin therapy in patients after acuter myocardial infarction. ACT Study results Кардиоваскулярная терапия и профилактика ацетилсалициловая кислота инфаркт миокарда приверженность (compliance) исследование act |
| title | Compliance to preventive aspirin therapy in patients after acuter myocardial infarction. ACT Study results |
| title_full | Compliance to preventive aspirin therapy in patients after acuter myocardial infarction. ACT Study results |
| title_fullStr | Compliance to preventive aspirin therapy in patients after acuter myocardial infarction. ACT Study results |
| title_full_unstemmed | Compliance to preventive aspirin therapy in patients after acuter myocardial infarction. ACT Study results |
| title_short | Compliance to preventive aspirin therapy in patients after acuter myocardial infarction. ACT Study results |
| title_sort | compliance to preventive aspirin therapy in patients after acuter myocardial infarction act study results |
| topic | ацетилсалициловая кислота инфаркт миокарда приверженность (compliance) исследование act |
| url | https://cardiovascular.elpub.ru/jour/article/view/2130 |
| work_keys_str_mv | AT vmgorbunov compliancetopreventiveaspirintherapyinpatientsafteracutermyocardialinfarctionactstudyresults |